This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Up to €1,300 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 23–25, 2026
FIL (Feira Internacional de Lisboa), Lisbon, PortugalMarch 31 – April 1, 2026 | Digital Partnering

Neal Koller
CEO and founder at Alphyn Biologics
Presenter

Profile

A founder of Alphyn, Mr. Koller has served as the company’s CEO and Chairman of the Board since the company started in November 2019. He has been President & CEO, and Director for six life science businesses, guiding them to milestone achievement or exit. Before Alphyn, Mr. Koller was President & CEO and board member of Perthera, Inc., preceded by the same positions at PluroGen Therapeutics, Inc. Mr. Koller established Plurogen’s manufacturing, research and development, and operations facility and launched products into U.S. & international markets, exiting to a multi-national. Additionally, Mr. Koller held positions as President of PDA, CEO of Sound Diagnostics Inc., President & CEO of Dovetail Technologies Inc., and President of WellCare International Corp. He began his career at Wyeth Pharmaceuticals, where he achieved notable successes in both large division and early stage business roles. He has a B.S. in biology from the University of Richmond.